Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0001193125-26-267605

Options or other derivatives

  • Director acquired 73,318 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Walker Neal · Director

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-06-09 Grant or award : show line 1 in the form Stock Option (Right to Buy) +70,000 70,000 D
2026-06-09 Grant or award : show line 2 in the form Stock Option (Right to Buy) +3,318 3,318 D
Loading xslF345X06/ownership.xml…